Chris M photo

Dr. Chris Martin, MBA, FIChemE

Chris has over 20 years experience in the pharmaceutical and biotech sector. He is Chief Executive of ADC Therapeutics, a drug discovery company pioneering DNA targeted anti-cancer therapies. Chris was previously the founder and Chief Executive of Spirogen Ltd, non-executive Chairman of Sciona, Inc. and a founder of Paras Ltd. and worked as a consultant in the healthcare industry for ten years. He is a director of Finsbury Technology Trust and Xenva Ltd. Chris is a Fellow of the Institution of Chemical Engineers and a Sainsbury Management Fellow (MBA, IMD 1989).